This inventor holds 4 USPTO granted patents and 3 EPO patents. Top assignees: Fujisawa Pharmaceutical Company, Ltd., Astellas Pharma Gmbh. Active years: 2002-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Muko, JP (2002)
- Kyoto, JP (2003 - 2005)
- Kyota, JP (2013)
Company Filing History:
Years Active: 2002-2013
Title: The Innovative Mind of Kazunari Yamashita
Introduction
Kazunari Yamashita, an accomplished inventor based in Kyota, Japan, has made significant contributions to the field of pharmaceutical formulations. With a total of four patents to his name, Yamashita's work focuses on sustained-release formulations that play a crucial role in organ transplantation and autoimmune disease management.
Latest Patents
Among his most notable patents is a sustained-release formulation that comprises a solid dispersion composition, which includes a tricyclic compound or a pharmaceutically acceptable salt in a combination of water-soluble and water-insoluble polymers, along with excipients. Another significant patent features a sustained-release formulation containing tacrolimus or its hydrate. This formulation emphasizes a precise dissolution time (T63.2%) of 0.7 to 15 hours, as determined by the Japanese Pharmacopoeia, 13th edition, using a well-defined dissolution test method. Designed for administration once a day, this innovative formulation aids in preventing organ or tissue rejection during transplantation or treats autoimmune diseases. It may be presented in various forms, including powder, granules, tablets, or capsules.
Career Highlights
Yamashita has a strong professional background, having worked for prominent pharmaceutical companies, namely Fujisawa Pharmaceutical Company, Ltd. and Astellas Pharma GmbH. His dedication and expertise have propelled innovations in drug formulations that enhance patient outcomes.
Collaborations
Throughout his career, Kazunari Yamashita has collaborated with noted professionals such as Eiji Hashimoto and Yukihiro Nomura. These partnerships have significantly contributed to the progression of his inventions and the overall field of pharmaceutical research.
Conclusion
Kazunari Yamashita stands out as a leading inventor in sustainable pharmaceutical innovations. His dedication to advancing medical formulations demonstrates a commitment to improving health outcomes through innovative solutions. The impact of his work continues to resonate in the pharmaceutical industry, reflecting the importance of such innovations in modern medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile